{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:52:04Z","timestamp":1789080724739,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"vor","delay-in-days":115,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Mayo Foundation and the Mayo Department of Neurology and Mayo Center of Individualized Medicine"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Our study aims to quantitate neuromuscular morbidity from radiotherapy in Hodgkin lymphoma including: (i) frequency and (ii) time of onsets for neurological localizations; (iii) degree of disabilities and (iv) number of clinical visits compared to cardiopulmonary Hodgkin lymphoma-radiation complications. Medical records from Mayo Health systems were retrieved; identifying neuromuscular radiation treated Hodgkin lymphoma-complications from 1 January 1994 to 31 December 2016. Of an estimated 4100 post-radiotherapy Hodgkin lymphoma patients, 4.6% (189) were identified with complications. Mean latency to physician visit for symptoms was 23.7\u2009years (range: 1\u201350). Most commonly identified complications included: head drop 10% (19) with or without myopathy, myopathy 39% (73), plexopathy 29% (54), myelopathy 27% (51) and polyradiculopathy 13% (24). Other findings included benign and malignant nerve sheath tumours 5% (9), phrenic and long thoracic mononeuropathies 7% (14) and compressive spinal meningioma 2% (4). Patients frequently had multiple coexisting complications (single\u2009=\u200976% [144], double\u2009=\u200917% [33], triple\u2009=\u20094% [8], quadruple\u2009=\u20092% [4]). Cardiac 28% (53) and pulmonary 15% (29) complications were also seen in these patients. History of Hodgkin lymphoma was initially overlooked by neurologists (14.3%, 48\/336 clinical notes). Hospital and outpatient visits for complications were frequent: neuromuscular 19% (77\/411) versus cardiopulmonary 30% (125\/411). Testing was largely exclusionary, except when imaging identified secondary malignancy. Modified Rankin score at diagnosis varied: 0\u20131 (55.8%), 2\u20133 (5.8%) and 4\u20135 (38.3%). Neuromuscular complications among post-radiation Hodgkin lymphoma are diverse, occurring in \u223c1 of 20 having markedly delayed onsets often eluding diagnosis. Frequent care visits and major morbidity are common. Survivorship recommendations should recognize the diverse neurological complications.<\/jats:p>","DOI":"10.1093\/braincomms\/fcaa050","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T19:55:51Z","timestamp":1587844551000},"source":"Crossref","is-referenced-by-count":8,"title":["Expanded neuromuscular morbidity in Hodgkin lymphoma after radiotherapy"],"prefix":"10.1093","volume":"2","author":[{"given":"Tatsuya","family":"Oishi","sequence":"first","affiliation":[{"name":"Department\u00a0of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory J","family":"Kogelschatz","sequence":"additional","affiliation":[{"name":"Department\u00a0of Neurology, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Intermountain Neurosciences Institute, Murray, UT 84107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P","family":"Young","sequence":"additional","affiliation":[{"name":"Department\u00a0of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest M","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Department\u00a0of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P","family":"Staff","sequence":"additional","affiliation":[{"name":"Department\u00a0of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue L","family":"Visscher","sequence":"additional","affiliation":[{"name":"Center of the Science of Health Care Delivery, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan J","family":"Borah","sequence":"additional","affiliation":[{"name":"Center of the Science of Health Care Delivery, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E","family":"Krauss","sequence":"additional","affiliation":[{"name":"Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kogulavadanan","family":"Arumaithurai","sequence":"additional","affiliation":[{"name":"Department\u00a0of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahar","family":"Shelly","sequence":"additional","affiliation":[{"name":"Department\u00a0of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Ansell","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Klein","sequence":"additional","affiliation":[{"name":"Department\u00a0of Neurology, Mayo Clinic, Rochester, MN 55905, USA"},{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,25]]},"reference":[{"key":"2020081109071251600_fcaa050-B1","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","author":"Andre","year":"2017","journal-title":"J Clin Oncol"},{"key":"2020081109071251600_fcaa050-B2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.mayocp.2015.07.005","article-title":"Hodgkin lymphoma: diagnosis and treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"2020081109071251600_fcaa050-B3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ajh.25071","article-title":"Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management","volume":"93","author":"Ansell","year":"2018","journal-title":"Am J Hematol"},{"key":"2020081109071251600_fcaa050-B4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2020081109071251600_fcaa050-B5","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2017-10-772665","article-title":"Balancing risk and benefit in early-stage classical Hodgkin lymphoma","volume":"131","author":"Brockelmann","year":"2018","journal-title":"Blood"},{"key":"2020081109071251600_fcaa050-B6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10143-004-0366-1","article-title":"Radiation-induced intracranial meningiomas: review of six operated cases","volume":"28","author":"De Tommasi","year":"2005","journal-title":"Neurosurg Rev"},{"key":"2020081109071251600_fcaa050-B7","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.2003.03.023","article-title":"Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin\u2019s lymphoma: results of the HD8 trial of the German Hodgkin\u2019s Lymphoma Study Group","volume":"21","author":"Engert","year":"2003","journal-title":"J Clin Oncol"},{"key":"2020081109071251600_fcaa050-B8","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus involved-field radiation in early-stage Hodgkin\u2019s disease","volume":"357","author":"Ferme","year":"2007","journal-title":"N Engl J Med"},{"key":"2020081109071251600_fcaa050-B9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2014.01.041","article-title":"Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma","volume":"89","author":"Filippi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020081109071251600_fcaa050-B10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp-2013-307447","article-title":"Clinical and laboratory findings of 21 patients with radiation-induced myopathy","volume":"86","author":"Ghosh","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020081109071251600_fcaa050-B11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0030-6657(07)70517-6","article-title":"Radiation induced leiomyosarcoma. Review of literature and case report","volume":"61","author":"Grabowska","year":"2007","journal-title":"Otolaryngol Pol"},{"key":"2020081109071251600_fcaa050-B12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mus.880141102","article-title":"AAEM minimonograph #37: facial and limb myokymia","volume":"14","author":"Gutmann","year":"1991","journal-title":"Muscle Nerve"},{"key":"2020081109071251600_fcaa050-B13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/1097-0142(19950101)75:1<94::AID-CNCR2820750116>3.0.CO;2-#","article-title":"Hodgkin\u2019s disease with spinal cord compression. A case report and a review of the literature","volume":"75","author":"Higgins","year":"1995","journal-title":"Cancer"},{"key":"2020081109071251600_fcaa050-B14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1056\/NEJMe1715141","article-title":"Progress in the treatment of Hodgkin\u2019s lymphoma","volume":"378","author":"Longo","year":"2018","journal-title":"N Engl J Med"},{"key":"2020081109071251600_fcaa050-B15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0009-9260(69)80068-1","article-title":"Radiation induced intracranial meningiomas","volume":"20","author":"Munk","year":"1969","journal-title":"Clin Radiol"},{"key":"2020081109071251600_fcaa050-B16","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1182\/blood-2014-05-579193","article-title":"Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects","volume":"124","author":"Ng","year":"2014","journal-title":"Blood"},{"key":"2020081109071251600_fcaa050-B17","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.spinee.2010.12.003","article-title":"Meningioma of the conus medullaris mimicking neurofibroma\u2013possibly radiation induced","volume":"11","author":"Oikonomou","year":"2011","journal-title":"Spine J"},{"key":"2020081109071251600_fcaa050-B18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/0284186X.2014.932435","article-title":"Prospective phase II trial of image-guided radiotherapy in Hodgkin lymphoma: benefit of deep inspiration breath-hold","volume":"54","author":"Petersen","year":"2015","journal-title":"Acta Oncol"},{"key":"2020081109071251600_fcaa050-B19","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1212\/WNL.0000000000004693","article-title":"Radiation-induced spinal nerve root cavernous malformations as a rare cause of radiculopathy","volume":"89","author":"Rastogi","year":"2017","journal-title":"Neurology"},{"key":"2020081109071251600_fcaa050-B20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/mus.20623","article-title":"Late appearance of dropped head syndrome after radiotherapy for Hodgkin\u2019s disease","volume":"34","author":"Rowin","year":"2006","journal-title":"Muscle Nerve"},{"key":"2020081109071251600_fcaa050-B21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2020081109071251600_fcaa050-B22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG)","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020081109071251600_fcaa050-B23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.pmrj.2011.08.535","article-title":"Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors","volume":"3","author":"Stubblefield","year":"2011","journal-title":"PM R"},{"key":"2020081109071251600_fcaa050-B24","first-page":"1031","article-title":"Neuromuscular complications of radiation therapy","volume":"56","author":"Stubblefield","year":"2017","journal-title":"Muscle Nerve"},{"key":"2020081109071251600_fcaa050-B25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)60035-X","article-title":"Hodgkin\u2019s lymphoma in adults","volume":"380","author":"Townsend","year":"2012","journal-title":"Lancet"},{"key":"2020081109071251600_fcaa050-B26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ijrobp.2010.11.064","article-title":"Progressive muscle atrophy and weakness after treatment by Mantle Field radiotherapy in Hodgkin lymphoma survivors","volume":"82","author":"van Leeuwen-Segarceanu","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"2020081109071251600_fcaa050-B27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11899-014-0222-5","article-title":"Chemotherapy only in early-stage Hodgkin lymphoma: more relapses but \u201csame\u201d (or possibly worse) survival\u2013reconsidering the misguided trend to omit radiotherapy","volume":"9","author":"Yahalom","year":"2014","journal-title":"Curr Hematol Malig Rep"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcaa050\/33128962\/fcaa050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/braincomms\/article-pdf\/2\/1\/fcaa050\/33639825\/fcaa050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/braincomms\/article-pdf\/2\/1\/fcaa050\/33639825\/fcaa050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T20:50:57Z","timestamp":1597179057000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcaa050\/5825280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcaa050","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020]]},"published":{"date-parts":[[2020,1,1]]},"article-number":"fcaa050"}}